AI-powered genomic mutation signature for predicting immune checkpoint inhibitor therapy outcomes in gastroesophageal cancer: a multi-cohort analysis

Abstract Background Immune checkpoint inhibitors (ICIs) have significantly transformed the treatment of gastroesophageal cancer (GEC). However, the lack of reliable prognostic biomarkers hinders the ability to predict patient response to ICI therapy. Methods In this study, we engineered and validate...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Bingyin Yang, Cuie Cheng, Jingfang Zhou, Haoxiang Ni, Haoran Liu, Yiwei Fu, Rui Li
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Springer 2024-09-01
Saila:	Discover Oncology
Gaiak:	Artificial intelligence Gastrointestinal cancer Genomic mutation Immunotherapy Immune landscape
Sarrera elektronikoa:	https://doi.org/10.1007/s12672-024-01400-7
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!